Patents by Inventor Gautam Daftary

Gautam Daftary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intravenous Propofol emulsion compositions having preservative efficacy
    Publication number: 20070249730
    Abstract: The invention discloses a stable intravenous Propofol oil-in-water emulsion composition having mixed preservatives of low toxicity that is capable of withstanding accidental contamination of bacteria and fungi. The preservative system employed comprising of monoglyceryl ester of lauric acid (Monolaurin) and a member selected from (a) capric acid and/or its soluble alkaline salts or its monoglyceryl ester (Monocaprin); (b) edetate; and (c) capric acid and/or its soluble alkaline salts or its monoglyceryl ester (Monocaprin) and edetate.
    Type: Application
    Filed: March 2, 2007
    Publication date: October 25, 2007
    Inventors: Gautam Daftary, Srikanth Pai, Girish Shanbhag, Sangeeta Rivankar
  • Liquid stable composition of oxazaphosphorine with mesna
    Publication number: 20050272698
    Abstract: A low toxicity, stable oxazaphosphorine containing compositions with mesna for parenteral administration has been described. The process essentially requires addition of an oxazaphosphorine antineoplastic to the aqueous solution of an etherified ?-cyclodextrin followed by addition of mesna as such or as an aqueous solution containing optionally, an etherified ?-cyclodextrin. Preferably, the oxazaphosphorine antineoplastic is Ifosfamide and the etherified ?-cyclodextrin is 2-hydroxypropyl-?-cyclodextrin.
    Type: Application
    Filed: September 4, 2003
    Publication date: December 8, 2005
    Inventors: Gautam Daftary, Srikanth Pai, Sangeeta Rivankar, Kumar Praveen
  • Non-pegylated long-circulating liposomes
    Publication number: 20050142178
    Abstract: The present invention provides a long circulating non-pegylated liposomal doxorubicin hydrochloride composition for parenteral administration and a process for its preparation. The circulation time in Swiss albino mice is at least 25 times longer than conventional non-liposomal formulations. The non-pegylated liposomes are stable, exhibit low toxicity and have been found to be efficacious in different tumor models.
    Type: Application
    Filed: December 31, 2003
    Publication date: June 30, 2005
    Applicant: Bharats Serums & Vaccines LTd.
    Inventors: Gautam Daftary, Srikanth Pai, Sangeeta Rivankar